Skip to main content
Home
FULL MENU Close Menu
Home
Home

Whitney McKnight

Article

December 2017: Click for Credit

Author:
Kari Oakes
Mitchel L. Zoler, PhD
Gina Henderson
Doug Brunk
Whitney McKnight

Topics include: Recurrent strep throat • Motivational pharmacotherapy for minority patients with depression • Revised Bethesda System thyroid...

  • Read More

News

IV ketamine proves superior to active placebo in low, high doses

Author:
Whitney McKnight
Publish date: August 14, 2017

MIAMI – Researchers close in on a range of ketamine doses that could provide temporary relief for patients with treatment-resistant depression.

  • Read More

News

‘Motivational pharmacotherapy’ engages Latino patients with depression

Author:
Whitney McKnight
Publish date: August 14, 2017

MIAMI – Delivering pharmacotherapy in a culturally sensitive way can help improve antidepressant adherence.

  • Read More

News

Continuous glucose monitors aren’t just for abdomens anymore

Author:
Whitney McKnight
Publish date: August 8, 2017

Personal photos of real-time continuous glucose monitors posted to online forums dedicated to diabetes management lead to questions about whether...

  • Read More

News

Senate confirms first mental health czar

Author:
Whitney McKnight
Publish date: August 7, 2017

Dr. Elinore F. McCance-Katz, a psychiatrist, is an expert in using pharmacotherapy for treating substance use disorders.

  • Read More

News

FDA approves faster, pangenotypic cure for hep C virus

Author:
Whitney McKnight
Publish date: August 7, 2017

A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.

  • Read More

News

FDA approves faster, pangenotypic cure for hep C virus

Author:
Whitney McKnight
Publish date: August 4, 2017

A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.

  • Read More

Video

VIDEO: What role does autoimmune dysfunction play in schizophrenia?

Author:
Whitney McKnight
Publish date: August 4, 2017

Researchers are studying the role autoimmune reactions such as inflammation play in the pathogenesis of schizophrenia, with and without comorbid...

  • Read More

News

More treatments becoming available for tardive dyskinesia

Author:
Whitney McKnight
Publish date: July 26, 2017

MIAMI – A second VMAT2 inhibitor may join Ingrezza as a safe and effective treatment for the movement disorder.

  • Read More

News

Expert: Engage patients, clinicians as partners in research

Author:
Whitney McKnight
Publish date: July 17, 2017

MIAMI – A new research paradigm treats every case as an N of 1 that could improve the care of millions.

  • Read More

News

VA/DOD elevate psychotherapy over medication in updated PTSD guidelines

Author:
Whitney McKnight
Publish date: July 11, 2017

MIAMI – Should trauma-focused psychotherapy supplant medication for first-line treatment?

  • Read More

News

Patients’ profile deemed best criteria for LAIs in bipolar disorder

Author:
Whitney McKnight
Publish date: July 10, 2017

MIAMI – Bipolar disorder patients with very severe illness, or who are at the more extreme spectrum in terms of risk, might not be receiving...

  • Read More

News

Reframe view of borderline personality disorder patients as survivors

Author:
Whitney McKnight
Publish date: July 6, 2017

WASHINGTON – Consider that patients with borderline personality disorder are wired for threats and can be helped by positive reinforcement, an...

  • Read More

News

First-episode psychosis is a ‘brain attack,’ and LAIs can prevent recurrence, expert says

Author:
Whitney McKnight
Publish date: July 6, 2017

Dr. Henry A. Nasrallah urges psychiatrists to start thinking of long-acting injectables as a tool to prevent relapse in patients experiencing...

  • Read More

News

Novel female sexual dysfunction drug effective, phase III studies show

Author:
Whitney McKnight
Publish date: June 19, 2017

Bremelanotide, which is administered subcutaneously, addresses low female sexual desire that is biological in nature.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close